Delivery Order SPE2DB24D2012-SPE2DB25FBWXG
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.77 by the Defense Logistics Agency (DLA) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100, to be delivered to the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement on a non-set-aside basis. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,919.32 on August 15, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units). This firm fixed-price contract, which is scheduled for completion by August 18, 2025, was issued without a set-aside designation and represents a competitively awarded procurement through the Defense Logistics Agency's Medical Supply Chain. The contract...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on August 7, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver 100 tablets of Ambien CR 6.25 mg for a ceiling value of $2,469.39. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 8, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count) valued at $2,354.12. This competitive award, issued with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $3,439.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract, which is not subject to any set-aside designation, was competitively awarded and carries an ultimate completion date of August 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the location from which this major...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4,979 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This is a firm fixed-price, non-set-aside contract with a completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,358.09 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 12.5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by August 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ambien CR 6.25 mg tablets in a quantity of 100 units, valued at $2,148.62. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWXGDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for federal military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has been designated as a prime vendor for the Defense Logistics Agency's global pharmaceutical supply chain, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order represents one of numerous small-value pharmaceutical transactions the company fulfills under its master IDC, which encompasses a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/8/25 |